AtomX SRL
The score of AtomX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AtomX's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
AtomX's financial analysis
- Solvency67.5%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AtomX
AtomX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0789.299.094
- VAT number
- BE0789299094
- Peppol
- Registered · 0208:0789299094 · as of 01 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Aug 2022
- Registered office
- 1450 Chastre
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
AtomX (SRL) has been based in Chastre since 2022, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 22,182 € and equity of 22,089 €; its revenue is not published. Its solvency stands at 67.5%, above the median of its sector (58.2%).
Companies similar to AtomX
Companies in the same business, of comparable size and area, outside its group.
- Immunofusion Research and experimental development on natural sciences and engineering Charleroi · balance sheet 32,131 €
- Cmax Biotech Consulting Research and experimental development on natural sciences and engineering Hasselt · balance sheet 52,078 €
- 1889 Consulting Research and experimental development on natural sciences and engineering Forest · balance sheet 42,356 €
- VKJ-Engineering Research and experimental development on natural sciences and engineering Heist-op-den-Berg · balance sheet 41,764 €
- Trenker Nutrition Research and experimental development on natural sciences and engineering Nivelles · balance sheet 72,988 €
- DT Research & Development Research and experimental development on natural sciences and engineering Brussels · balance sheet 7,943 €
- VVnet Research and experimental development on natural sciences and engineering Ghent · balance sheet 19,002 €
- Emelie Flemming-Parker Research and experimental development on natural sciences and engineering Tongeren-Borgloon · balance sheet 114,901 €
Frequently asked questions about AtomX
What is the revenue of AtomX?
AtomX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AtomX?
In Belgium, the VAT number is the company number prefixed with BE: BE0789299094 for AtomX, if the company is VAT-registered. Its company number (CBE) is 0789.299.094.
Where is the registered office of AtomX?
According to the CBE register, the registered office of AtomX is in 1450 Chastre.
What is the equity of AtomX?
At the close of the 2025 financial year, the equity of AtomX amounts to 22,089 €, a solvency of 67.5% of total assets.
Who manages AtomX?
The register lists 1 active mandates at AtomX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AtomX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →